Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Is Allogeneic Transplantation for Sickle Cell Disease Still Relevant in the Era of Gene Therapy?

Richard J. Jones, Adetola A. Kassim, Robert A. Brodsky, Michael R DeBaun

Blood Adv bloodadvances.2024013693.

https://doi.org/10.1182/bloodadvances.2024013693

Published: 2024

Journal Articles

Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease

Tami D. John, Mark C. Walters, Hemalatha G. Rangarajan, Mahvish Q. Rahim, Christopher McKinney, Catherine M. Bollard, Ghada Abusin, Mary Eapen, Adetola A. Kassim, Michael R. DeBaun

Blood Adv (2024) 8 (23): 6055–6063.

https://doi.org/10.1182/bloodadvances.2024014078

Published: 2024

Includes: Supplemental data

Journal Articles

Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial

Jose Mejias, Alejandro R. Gonzalez-Barreto, Mark Rodeghier, Michael R. DeBaun

Blood Adv (2024) 8 (22): 5853–5854.

https://doi.org/10.1182/bloodadvances.2024013216

Published: 2024

Includes: Supplemental data

Journal Articles

Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease

Megan A. Aumann, Wesley Richerson, Alexander K. Song, L. Taylor Davis, Sumit Pruthi, Samantha Davis, Niral J. Patel, Chelsea Custer, Adetola A. Kassim, Michael R. DeBaun, Manus J. Donahue, Lori C. Jordan

Blood Adv (2024) 8 (3): 608–619.

https://doi.org/10.1182/bloodadvances.2023010717

Published: 2024

Includes: Supplemental data

Journal Articles

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries

Lauren Jane Klein, Shehu Umar Abdullahi, Safiya Gambo, Virginia A. Stallings, Sari Acra, Mark Rodeghier, Michael R. DeBaun

Blood Adv (2023) 7 (22): 6923–6930.

https://doi.org/10.1182/bloodadvances.2023009711

Published: 2023

Includes: Supplemental data

Journal Articles

A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD

Robert M. Cronin, Nives Quaye, Xin Liu, Kristina Landes, Lori E. Crosby, Adetola A. Kassim, Emmanuel J. Volanakis, Patrick M. Schnell, Michael R. DeBaun

Blood Adv (2023) 7 (20): 6184–6190.

https://doi.org/10.1182/bloodadvances.2023010676

Published: 2023

Includes: Supplemental data

Journal Articles

Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria

Shehu U. Abdullahi, Safiya Gambo, Hassan Adam Murtala, Halima Kabir, Khadija A. Shamsu, Garba Gwarzo, Sari Acra, Virginia A. Stallings, Mark Rodeghier, Michael R. DeBaun, Lauren J. Klein

Blood Adv (2023) 7 (20): 6024–6034.

https://doi.org/10.1182/bloodadvances.2023010789

Published: 2023

Includes: Supplemental data

Journal Articles

Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy

Robert M. Cronin, Kristin Wuichet, Djamila L Ghafuri, Brock Hodges, Maya Chopra, Jing He, Xinnan Niu, Adetola A. Kassim, Karina Wilkerson, Mark Rodeghier, Michael R. DeBaun

Blood Adv (2023) 7 (15): 3775–3782.

https://doi.org/10.1182/bloodadvances.2022008692

Published: 2023

Includes: Supplemental data

Journal Articles

Most adults with severe HbSC disease are not treated with hydroxyurea

William Kwesi Ghunney, Eugenia Vicky Asare, John Benaiah Ayete-Nyampong, Samuel Antwi Oppong, Mark Rodeghier, Michael R. DeBaun, Edeghonghon Olayemi

Blood Adv (2023) 7 (13): 3312–3319.

https://doi.org/10.1182/bloodadvances.2022009049

Published: 2023

Journal Articles

The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease

Robert M. Cronin, Chyongchiou J. Lin, ChienWei Chiang, Sarah R. MacEwan, Michael R. DeBaun, J. Madison Hyer

Blood Adv (2023) 7 (13): 3114–3116.

https://doi.org/10.1182/bloodadvances.2022008965

Published: 2023

Includes: Supplemental data

Journal Articles

Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting

Lauren J. Klein, Shehu Umar Abdullahi, Safiya Gambo, Virginia A. Stallings, Sari Acra, Mark Rodeghier, Michael R. DeBaun

Blood Adv (2023) 7 (11): 2339–2346.

https://doi.org/10.1182/bloodadvances.2022008623

Published: 2023

Includes: Supplemental data

Journal Articles

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis

Ibrahim M. Idris, Akib Abba, Jamil A. Galadanci, Sani A. Aji, Atiku U. Jibrilla, Mark Rodeghier, Adetola Kassim, Arthur L. Burnett, Michael R. DeBaun

Blood Adv (2022) 6 (20): 5676–5683.

https://doi.org/10.1182/bloodadvances.2022007285

Published: 2022

Includes: Supplemental data

Journal Articles

Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease

Maya Chopra, Jeannie Byrd, Kristin Wuichet, Michael R. DeBaun

Blood Adv (2022) 6 (16): 4831–4833.

https://doi.org/10.1182/bloodadvances.2022007600

Published: 2022

Journal Articles

Sustainability of low maternal mortality in pregnant women with SCD in a low-resource setting

Alim Swarray-Deen, Eugenia V. Asare, Ruth Ayettey Brew, John Benaiah Ayete-Nyampong, Yvonne Dei-Adomakoh, Edeghonghon Olayemi, Enoch Mensah, Yvonne Osei-Bonsu, Selina Crabbe, William K. Ghunney, Charles Hayfron-Benjamin, Titus Beyuo, Theodore Boafor, Adetola A. Kassim, Mark Rodeghier, Michael R. DeBaun, Samuel A. Oppong

Blood Adv (2022) 6 (7): 1977–1980.

https://doi.org/10.1182/bloodadvances.2021005942

Published: 2022

Journal Articles

Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis

Brock Hodges, Zalaya Ivy, Robert M. Cronin, Mark Rodeghier, Michael R. DeBaun, Shaina M. Willen

Blood Adv (2022) 6 (6): 1937–1940.

https://doi.org/10.1182/bloodadvances.2021006527

Published: 2022

Includes: Supplemental data

Journal Articles

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial

Peter Hsu, James C. Gay, Chyongchiou J. Lin, Mark Rodeghier, Michael R. DeBaun, Robert M. Cronin

Blood Adv (2021) 5 (23): 5032–5040.

https://doi.org/10.1182/bloodadvances.2021004864

Published: 2021

Journal Articles

Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease

Ibrahim M. Idris, Akib Abba, Jamil A. Galadanci, Sharfuddeen A. Mashi, Nafiu Hussaini, Sagir Ahmed Gumel, Arthur L. Burnett, Michael R. DeBaun

Blood Adv (2020) 4 (14): 3277–3283.

https://doi.org/10.1182/bloodadvances.2020002062

Published: 2020

Includes: Supplemental data

Journal Articles

Phase 2 trial of montelukast for prevention of pain in sickle cell disease

Joshua J. Field, Adetola Kassim, Amanda Brandow, Stephen H. Embury, Neil Matsui, Karina Wilkerson, Valencia Bryant, Liyun Zhang, Pippa Simpson, Michael R. DeBaun

Blood Adv (2020) 4 (6): 1159–1165.

https://doi.org/10.1182/bloodadvances.2019001165

Published: 2020

Includes: Supplemental data

Journal Articles

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain

Blood Adv (2019) 3 (23): 3982–4001.

https://doi.org/10.1182/bloodadvances.2019000882

Published: 2019

Includes: Supplemental data

Journal Articles

2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations

M. Hassan Murad, Robert I. Liem, Eddy S. Lang, Elie A. Akl, Joerg J. Meerpohl, Michael R. DeBaun, John F. Tisdale, Amanda M. Brandow, Sophie M. Lanzkron, Stella T. Chou, Starr Webb, Reem A. Mustafa

Blood Adv (2019) 3 (23): 3945–3950.

https://doi.org/10.1182/bloodadvances.2019000931

Published: 2019

NARROW

Is Allogeneic Transplantation for Sickle Cell Disease Still Relevant in the Era of Gene Therapy?

Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease

Evaluation of hemoglobin S percent threshold to prevent severe pain events: a secondary analysis of the SIT trial

Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease

Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries

A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD

Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria

Creating an automated contemporaneous cohort in sickle cell anemia to predict survival after disease-modifying therapy

Most adults with severe HbSC disease are not treated with hydroxyurea

The use of FDA-approved medications for preventing vaso-occlusive events in sickle cell disease

Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting

Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis

Sexual violence as a precipitator of chronic pain in young adults with sickle cell disease

Sustainability of low maternal mortality in pregnant women with SCD in a low-resource setting

Annual decline in lung function in adults with sickle cell disease is similar to that observed in adults with cystic fibrosis

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial

Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease

Phase 2 trial of montelukast for prevention of pain in sickle cell disease

End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain

2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only